{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:27:36Z","timestamp":1793165256237,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jcmg.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T14:12:00Z","timestamp":1533564720000},"page":"1084-1093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast\u00a0Cancer Patients"],"prefix":"10.1016","volume":"11","author":[{"given":"Mariana L.","family":"Henry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon H.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Chavez-MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2018.06.005_bib1","first-page":"86","article-title":"Comorbidities and cardiovascular disease risk in older breast cancer survivors","volume":"20","author":"Haque","year":"2014","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jcmg.2018.06.005_bib2","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1200\/JCO.2009.27.3615","article-title":"Trastuzumab induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation","volume":"28","author":"Cardinale","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1200\/JCO.2007.13.5467","article-title":"Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial","volume":"26","author":"Perez","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib4","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1200\/JCO.2011.40.0010","volume":"30","author":"Romond","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib5","first-page":"190","article-title":"Cardiac side effects of trastuzumab in breast cancer patients - single center experiences","volume":"17","author":"Huszno","year":"2013","journal-title":"Contemp Oncol (Pozn)"},{"key":"10.1016\/j.jcmg.2018.06.005_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4048\/jbc.2014.17.4.363","article-title":"Risk of trastuzumab-related cardiotoxicity in early breast cancer patients: a prospective observational study","volume":"17","author":"Xue","year":"2014","journal-title":"J\u00a0Breast Cancer"},{"key":"10.1016\/j.jcmg.2018.06.005_bib7","unstructured":"National Comprehensive Cancer Network. Clinical Practice Guideline in Oncology: Breast Cancer Bone Cancer (Version 1.2018). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed April 6, 2018."},{"key":"10.1016\/j.jcmg.2018.06.005_bib8","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1200\/JCO.2014.58.9465","article-title":"Cardiac monitoring during adjuvant trastuzumab-based chemotherapy among older patients with breast cancer","volume":"33","author":"Chavez-MacGregor","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib9","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1200\/JCO.2015.65.1505","article-title":"Breast cancer therapy-related cardiac dysfunction in adult women treated in routine clinical practice: a population-based cohort study","volume":"34","author":"Thavendiranathan","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1198\/000313005X70371","article-title":"Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator","volume":"59","author":"Snapinn","year":"2005","journal-title":"Am Stat"},{"key":"10.1016\/j.jcmg.2018.06.005_bib12","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.jacc.2012.07.068","article-title":"Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer","volume":"60","author":"Chen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1634\/theoncologist.2015-0230","article-title":"Cardiotoxicity and cardiac monitoring during adjuvant trastuzumab in daily Dutch practice: a study of the Southeast Netherlands Breast Cancer Consortium","volume":"21","author":"Seferina","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.jcmg.2018.06.005_bib14","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.9778\/cmajo.20150033","article-title":"Association of hospital and physician case volumes with cardiac monitoring and cardiotoxicity during adjuvant trastuzumab treatment for breast cancer: a retrospective cohort study","volume":"4","author":"Chin-Yee","year":"2016","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jcmg.2018.06.005_bib15","doi-asserted-by":"crossref","first-page":"e000472","DOI":"10.1161\/JAHA.113.000472","article-title":"Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer","volume":"3","author":"Ezaz","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jcmg.2018.06.005_bib16","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1200\/JCO.2013.48.7884","article-title":"Trastuzumab-related cardiotoxicity among older patients with breast cancer","volume":"31","author":"Chavez-MacGregor","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib17","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1200\/JCO.2009.26.0125","article-title":"Trastuzumab-related cardiotoxicity following anthracycline-based adjuvant chemotherapy: how worried should we be?","volume":"28","author":"Morris","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1158\/1078-0432.CCR-07-1033","article-title":"Cardiac toxicity in breast cancer survivors: review of potential cardiac problems","volume":"14","author":"Bird","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmg.2018.06.005_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/EDE.0000000000000394","article-title":"Cardiovascular disease mortality among breast cancer survivors","volume":"27","author":"Bradshaw","year":"2016","journal-title":"Epidemiology"},{"key":"10.1016\/j.jcmg.2018.06.005_bib20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.breast.2013.04.011","article-title":"Trastuzumab therapy in Australia: which patients with HER2+ metastatic breast cancer are assessed for cardiac function?","volume":"22","author":"Lu","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.jcmg.2018.06.005_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cardfail.2011.10.015","article-title":"Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer","volume":"18","author":"Tarantini","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jcmg.2018.06.005_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1524-4741.2011.01101.x","article-title":"Lack of uniformity in cardiac assessment during trastuzumab therapy","volume":"17","author":"Subar","year":"2011","journal-title":"Breast J"},{"key":"10.1016\/j.jcmg.2018.06.005_bib23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.bjc.6604909","article-title":"Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring","volume":"100","author":"Jones","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcmg.2018.06.005_bib24","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1200\/JCO.2016.67.4846","article-title":"Obesity As a risk factor for anthracyclines and trastuzumab cardiotoxicity in breast cancer: a systematic review and meta-analysis","volume":"34","author":"Guenancia","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib25","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1200\/JCO.2015.64.5515","article-title":"Cardiac surveillance guidelines for trastuzumab-containing therapy in early-stage breast cancer: getting to the heart of the matter","volume":"34","author":"Dang","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jamaoncol.2015.3709","article-title":"Cardiac outcomes of patients receiving adjuvant weekly paclitaxel and trastuzumab for node-negative, ERBB2positive breast cancer","volume":"2","author":"Dang","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jcmg.2018.06.005_bib27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X18305278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X18305278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:45:19Z","timestamp":1761846319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X18305278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1936878X18305278"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2018.06.005","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast\u00a0Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2018.02.027","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}